The role and importance of glycosylation of acute phase proteins with focus on alpha-1 antitrypsin in acute and chronic inflammatory conditions

Journal of Proteome Research

Volumn 13, Issue 7, 2014, Pages 3131-3143

  McCarthy, Cormac ^a   Saldova, Radka ^b   Wormald, Mark R ^c   Rudd, Pauline M ^b   McElvaney, Noel G ^a   Reeves, Emer P ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

alpha 1 antitrypsin; glycosylation; inflammation

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; GLYCAN; SERINE PROTEINASE INHIBITOR; TUMOR MARKER;

DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GLYCOSYLATION; HUMAN; INFLAMMATION; PLASMA HALF LIFE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; REVIEW; SMOKING; ACUTE DISEASE; ANIMAL; CHRONIC DISEASE; METABOLISM; PROTEIN PROCESSING;

ACUTE DISEASE; ALPHA 1-ANTITRYPSIN; ANIMALS; CHRONIC DISEASE; GLYCOSYLATION; HUMANS; INFLAMMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 84903697731     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500146y     Document Type: Review

References (174)

1. Law, R. H.; Zhang, Q.; McGowan, S.; Buckle, A. M.; Silverman, G. A.; Wong, W. An overview of the serpin superfamily GenomeBiology 2006, 7 (5) 216
2. Gettins, P. G. Serpin structure, mechanism, and function Chem. Rev. 2002, 102 (12) 4751-4804
3. Huntington, J. A. Serpin structure, function and dysfunction J. Thromb. Haemostasis 2011, 9 (Suppl 1) 26-34
4. Gooptu, B.; Lomas, D. A. Conformational pathology of the serpins: themes, variations, and therapeutic strategies Ann. Rev. Biochem. 2009, 78, 147-176
5. Elliott, P. R.; Lomas, D. A.; Carrell, R. W.; Abrahams, J. P. Inhibitory conformation of the reactive loop of alpha 1-antitrypsin Nat Struct Biol. 1996, 3 (8) 676-681
6. Elliott, P. R.; Pei, X. Y.; Dafforn, T. R.; Lomas, D. A. Topography of a 2.0 A structure of alpha-1-antitrypsin reveals targets for rational drug design to prevent conformational disease Protein Sci. 2000, 9 (7) 1274-1281
7. Huber, R.; Carrell, R. W. Implications of the three-dimensional structure of alpha-1-antitrypsin for structure and function of serpins Biochemistry 1989, 28 (23) 8951-8966
8. Perlmutter, D. H. Alpha-1-antitrypsin deficiency: diagnosis and treatment Clin. Liver Dis. 2004, 8 (4) 839-859 viii-ix
9. Voulgari, F.; Cummins, P.; Gardecki, T. I.; Beeching, N. J.; Stone, P. C.; Stuart, J. Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection Br. Heart J. 1982, 48 (4) 352-356
10. Correale, M.; Totaro, A.; Abruzzese, S.; Di Biase, M.; Brunetti, N. D. Acute phase proteins in acute coronary syndrome: An up-to-date Cardiovasc. Hematol. Agents Med. Chem. 2012, 10 (4) 352-361
11. Bergin, D. A.; Hurley, K.; McElvaney, N. G.; Reeves, E. P. Alpha-1 antitrypsin: A potent anti-inflammatory and potential novel therapeutic agent Arch. Immunol. Ther. Exp. (Warsz) 2012, 60 (2) 81-97
12. Bergin, D. A.; Reeves, E. P.; Meleady, P.; Henry, M.; McElvaney, O. J.; Carroll, T. P. Alpha-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8 J. Clin Invest. 2010, 120 (12) 4236-4250
13. Kolarich, D.; Weber, A.; Turecek, P. L.; Schwarz, H. P.; Altmann, F. Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms Proteomics 2006, 6 (11) 3369-3380
14. Mills, P. B.; Mills, K.; Johnson, A. W.; Clayton, P. T.; Winchester, B. G. Analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry of the post-translational modifications of alpha 1-antitrypsin isoforms separated by two-dimensional polyacrylamide gel electrophoresis Proteomics 2001, 1 (6) 778-786
15. Eriksson, S.; Alm, R.; Astedt, B. Organ cultures of human fetal hepatocytes in the study of extra-and intracellular alpha1-antitrypsin Biochim. Biophys. Acta 1978, 542 (3) 496-505
16. Koj, A.; Regoeczi, E.; Toews, C. J.; Leveille, R.; Gauldie, J. Synthesis of antithrombin III and alpha-1-antitrypsin by the perfused rat liver Biochim. Biophys. Acta 1978, 539 (4) 496-504
17. Mornex, J. F.; Chytil-Weir, A.; Martinet, Y.; Courtney, M.; LeCocq, J. P. Crystal RG. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals J. Clin. Invest. 1986, 77 (6) 1952-1961
18. Carroll, T. P.; Greene, C. M.; OConnor, C. A.; Nolan, A. M.; ONeill, S. J.; McElvaney, N. G. Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency J. Immunol. 2010, 184 (8) 4538-4546
19. Perlmutter, D. H.; Daniels, J. D.; Auerbach, H. S.; De Schryver-Kecskemeti, K.; Winter, H. S.; Alpers, D. H. The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line J. Biol. Chem. 1989, 264 (16) 9485-90
20. Cichy, J.; Potempa, J.; Travis, J. Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells J. Biol. Chem. 1997, 272 (13) 8250-8255
21. Greene, C. M.; McElvaney, N. G. Proteases and antiproteases in chronic neutrophilic lung disease-relevance to drug discovery Br. J. Pharmacol. 2009, 158 (4) 1048-1058
22. Kelly, E.; Greene, C. M.; Carroll, T. P.; McElvaney, N. G.; ONeill, S. J. Alpha-1 antitrypsin deficiency Respir. Med. 2010, 104 (6) 763-772
23. Curiel, D. T.; Chytil, A.; Courtney, M. Crystal RG. Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264 - - Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion J. Biol. Chem. 1989, 264 (18) 10477-10486
24. Lomas, D. A.; Evans, D. L.; Finch, J. T.; Carrell, R. W. The mechanism of Z alpha 1-antitrypsin accumulation in the liver Nature 1992, 357 (6379) 605-607
25. Ferrarotti, I.; Thun, G. A.; Zorzetto, M.; Ottaviani, S.; Imboden, M.; Schindler, C. Serum levels and genotype distribution of alpha1-antitrypsin in the general population Thorax 2012, 67 (8) 669-674
26. Carroll, T. P.; OConnor, C. A.; Floyd, O.; McPartlin, J.; Kelleher, D. P.; OBrien, G. The prevalence of alpha-1 antitrypsin deficiency in Ireland Respir. Res. 2011, 12, 91
27. Brantly, M.; Nukiwa, T.; Crystal, R. G. Molecular basis of alpha-1-antitrypsin deficiency Am. J. Med. 1988, 84 (6A) 13-31
28. Molloy, K.; Hersh, C. P.; Morris, V. B.; Carroll, T. P.; OConnor, C. A.; Lasky-Su, J. A. Clarification of the Risk of COPD in Alpha-1 Antitrypsin Deficiency PiMZ Heterozygotes Am. J. Respir. Crit. Care Med. 2014, 189 (4) 419-427
29. Abboud, R. T.; Ford, G. T.; Chapman, K. R. Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society Canadian Respir. J. 2001, 8 (2) 81-88
30. Chapman, K. R.; aBurdon, J. G.; Piitulainen, E.; Sanhaus, R. A.; Seersholm, N.; Stocks, J. M.; Huang, L.; Edelman, J. M.; McElvaney, N. G., IV Alpha1 Antitrypsin (A1AT) Preserves Lung Density In Homozygous Alpha1 Antitrypsin Deficiency (A1ATD); A Randomized, Placebo-Controlled Trial American journal of respiratory and critical care medicine C20. Late Breaking Abstracts in Clinical Trials. 2013, A6069
31. Dirksen, A.; Piitulainen, E.; Parr, D. G.; Deng, C.; Wencker, M.; Shaker, S. B. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency Eur. Respir. J. 2009, 33 (6) 1345-1353
32. Dirksen, A.; Dijkman, J. H.; Madsen, F.; Stoel, B.; Hutchison, D. C.; Ulrik, C. S. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy Am. J. Respir. Crit. Care Med. 1999, 160 (5 Pt 1) 1468-1472
33. Chapman, K. R.; Stockley, R. A.; Dawkins, C.; Wilkes, M. M.; Navickis, R. J. Augmentation therapy for alpha1 antitrypsin deficiency: A meta-analysis COPD 2009, 6 (3) 177-184
34. Wencker, M.; Fuhrmann, B.; Banik, N.; Konietzko, N. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor Chest 2001, 119 (3) 737-744
35. Seersholm, N.; Wencker, M.; Banik, N.; Viskum, K.; Dirksen, A.; Kok-Jensen, A. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group Eur. Respir. J. 1997, 10 (10) 2260-2263
36. McCarthy, C.; Dimitrov, B. D. Augmentation therapy for alpha-1 antitrypsin deficiency - not enough evidence to support its use yet! COPD 2010, 7 (3) 234
37. Stoller, J. K.; Aboussouan, L. S. A review of alpha1-antitrypsin deficiency Am. J. Respir. Crit. Care Med. 2012, 185 (3) 246-259
38. Greene, C. M.; Miller, S. D.; Carroll, T.; McLean, C.; OMahony, M.; Lawless, M. W. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations J. Inherited Metab. Dis. 2008, 31 (1) 21-34
39. Tuder, R. M.; Janciauskiene, S. M.; Petrache, I. Lung disease associated with alpha1-antitrypsin deficiency Proc. Am. Thorac. Soc. 2010, 7 (6) 381-386
40. Ekeowa, U. I.; Marciniak, S. J.; Lomas, D. A. Alpha(1)-antitrypsin deficiency and inflammation Expert Rev. Clin. Immunol. 2011, 7 (2) 243-252
41. Mulgrew, A. T.; Taggart, C. C.; McElvaney, N. G. Alpha-1-antitrypsin deficiency: current concepts Lung 2007, 185 (4) 191-201
42. Jeppsson, J. O.; Larsson, C.; Eriksson, S. Characterization of alpha1-antitrypsin in the inclusion bodies from the liver in alpha 1-antitrypsin deficiency New Engl. J. Med. 1975, 293 (12) 576-579
43. Cowden, D. I.; Fisher, G. E.; Weeks, R. L. A pilot study comparing the purity, functionality and isoform composition of alpha-1-proteinase inhibitor (human) products Curr. Med. Res. Opin. 2005, 21 (6) 877-883
44. Kolarich, D.; Turecek, P. L.; Weber, A.; Mitterer, A.; Graninger, M.; Matthiessen, P. Biochemical, molecular characterization, and glycoproteomic analyses of alpha(1)-proteinase inhibitor products used for replacement therapy Transfusion 2006, 46 (11) 1959-1977
45. Spiro, R. G. Glycoproteins Adv. Protein Chem. 1973, 27, 349-467
46. Rudd, P. M.; Dwek, R. A. Glycosylation: heterogeneity and the 3D structure of proteins Crit. Rev. Biochem. Mol. Biol. 1997, 32 (1) 1-100
47. Spiro, R. G. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds Glycobiology 2002, 12 (4) 43R-56R
48. Klausner, R. D.; Sitia, R. Protein degradation in the endoplasmic reticulum Cell. 1990, 62 (4) 611-614
49. Montreuil, J. Primary structure of glycoprotein glycans: Basis for the molecular biology of glycoproteins Adv. carbohydr. chem. biochem. 1980, 37, 157-223
50. Johansen, P. G.; Marshall, R. D.; Neuberger, A. Carbohydrates in protein. 3. The preparation and some of the properties of a glycopeptide from hens-egg albumin Biochem. J. 1961, 78, 518-527
51. Silberstein, S.; Gilmore, R. Biochemistry, molecular biology, and genetics of the oligosaccharyltransferase FASEB J. 1996, 10 (8) 849-858
52. Hubbard, S. C.; Ivatt, R. J. Synthesis and processing of asparagine-linked oligosaccharides Annu. Rev. Biochem. 1981, 50, 555-583
53. Livi, G. P.; Lillquist, J. S.; Miles, L. M.; Ferrara, A.; Sathe, G. M.; Simon, P. L. Secretion of N-glycosylated interleukin-1 beta in Saccharomyces cerevisiae using a leader peptide from Candida albicans. Effect of N-linked glycosylation on biological activity J. Biol. Chem. 1991, 266 (23) 15348-15355
54. Kasturi, L.; Eshleman, J. R.; Wunner, W. H.; Shakin-Eshleman, S. H. The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein J. Biol. Chem. 1995, 270 (24) 14756-14761
55. Bause, E. Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes Biochem. J. 1983, 209 (2) 331-336
56. Carson, D. D.; Earles, B. J.; Lennarz, W. J. Enhancement of protein glycosylation in tissue slices by dolichylphosphate J. Biol. Chem. 1981, 256 (22) 11552-11557
57. Van Schaftingen, E.; Jaeken, J. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I FEBS Lett. 1995, 377 (3) 318-320
58. Parekh, R. B.; Tse, A. G.; Dwek, R. A.; Williams, A. F.; Rademacher, T. W. Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil lectin recognition of rat Thy-1 EMBO J. 1987, 6 (5) 1233-1244
59. Schachter, H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides Biochem. Cell Biol. 1986, 64 (3) 163-181
60. Harpaz, N.; Schachter, H. Control of glycoprotein synthesis. Processing of asparagine-linked oligosaccharides by one or more rat liver Golgi alpha-D-mannosidases dependent on the prior action of UDP-N-acetylglucosamine: alpha-D-mannoside beta 2-N-acetylglucosaminyltransferase I J. Biol. Chem. 1980, 255 (10) 4894-4902
61. Itzkowitz, S. H.; Bloom, E. J.; Kokal, W. A.; Modin, G.; Hakomori, S.; Kim, Y. S. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients Cancer 1990, 66 (9) 1960-1966
62. Hiraizumi, S; Takasaki, S; Ohuchi, N; Harada, Y; Nose, M; Mori, S Altered glycosylation of membrane glycoproteins associated with human mammary carcinoma Jpn. J. Cancer Res. 1992, 83 (10) 1063-1072
63. De Graaf, T. W.; Van der Stelt, M. E.; Anbergen, M. G.; van Dijk, W. Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera J. Exp. Med. 1993, 177 (3) 657-666
64. Rudd, P. M.; Joao, H. C.; Coghill, E.; Fiten, P.; Saunders, M. R.; Opdenakker, G. Glycoforms modify the dynamic stability and functional activity of an enzyme Biochemistry 1994, 33 (1) 17-22
65. Leatherbarrow, R. J.; Dwek, R. A. Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: A novel C1q binding assay Mol. Immunol. 1984, 21 (4) 321-327
66. Flintegaard, T. V.; Thygesen, P.; Rahbek-Nielsen, H.; Levery, S. B.; Kristensen, C.; Clausen, H. N-glycosylation increases the circulatory half-life of human growth hormone Endocrinology. 2010, 151 (11) 5326-36
67. Wormald, M. R.; Rudd, P. M.; Harvey, D. J.; Chang, S. C.; Scragg, I. G.; Dwek, R. A. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides Biochemistry. 1997, 36 (6) 1370-1380
68. Mori, K.; Dwek, R. A.; Downing, A. K.; Opdenakker, G.; Rudd, P. M. The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator J. Biol. Chem. 1995, 270 (7) 3261-3267
69. Kornfeld, S. Structure and function of the mannose 6-phosphate/ insulinlike growth factor II receptors Annu. Rev. Biochem 1992, 61, 307-30
70. Pepys, M. B.; Rademacher, T. W.; Amatayakul-Chantler, S.; Williams, P.; Noble, G. E.; Hutchinson, W. L. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure Proc. Natl. Acad. Sci. U.S.A. 1994, 91 (12) 5602-5606
71. Lee, Y. C.; Townsend, R. R.; Hardy, M. R.; Lonngren, J.; Arnarp, J.; Haraldsson, M. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features J. Biol. Chem. 1983, 258 (1) 199-202
72. Rudd, P. M.; Elliott, T.; Cresswell, P.; Wilson, I. A.; Dwek, R. A. Glycosylation and the immune system Science 2001, 291 (5512) 2370-2376
73. Rudd, P. M.; Wormald, M. R.; Stanfield, R. L.; Huang, M.; Mattsson, N.; Speir, J. A. Roles for glycosylation of cell surface receptors involved in cellular immune recognition J. Mol. biol. 1999, 293 (2) 351-366
74. Marino, K; Saldova, R; Adamczyk, B; Rudd, P. M. Changes in serum N-glycosylation profiles: Functional significance and potential for diagnostics. In Carbohydrate Chemistry: Chemical and Biological Approaches; Rauter, A. P., Ed.; RSC Publishing: Londoon, 2012.
75. Royle, L.; Campbell, M. P.; Radcliffe, C. M.; White, D. M.; Harvey, D. J.; Abrahams, J. L. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software Anal. Biochem. 2008, 376 (1) 1-12
76. Knezevic, A.; Polasek, O.; Gornik, O.; Rudan, I.; Campbell, H.; Hayward, C. Variability, heritability and environmental determinants of human plasma N-glycome J. Proteome Res. 2009, 8 (2) 694-701
77. Yamada, E.; Tsukamoto, Y.; Sasaki, R.; Yagyu, K.; Takahashi, N. Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum Glycoconjugate J. 1997, 14 (3) 401-405
78. Knezevic, A.; Gornik, O.; Polasek, O.; Pucic, M.; Redzic, I.; Novokmet, M. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans Glycobiology 2010, 20 (8) 959-969
79. Saldova, R.; Huffman, J. E.; Adamczyk, B.; Muzinic, A.; Kattla, J. J.; Pucic, M. Association of medication with the human plasma N-glycome J. Proteome Res. 2012, 11 (3) 1821-1831
80. Lauc, G.; Huffman, J.; Hayward, C.; Knezevic, A.; Polasek, O.; Gornik, O. Genome-wide association study identifies FUT8 and ESR2 as co-regulators of a bi-antennary N-linked glycan A2 (GlcNAc2Man3GlcNAc2) in human plasma proteins Nat. Precedings 2009, 10101/npre.2009.2864.1
81. Lauc, G.; Essafi, A.; Huffman, J. E.; Hayward, C.; Knezevic, A.; Kattla, J. J. Genomics meets glycomics: The first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation PLoS Genet. 2010, 6 (12) e1001256
82. Sharp, L. K.; Mallya, M.; Kinghorn, K. J.; Wang, Z.; Crowther, D. C.; Huntington, J. A. Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis FEBS J. 2006, 273 (11) 2540-2552
83. Arnold, J. N.; Saldova, R.; Galligan, M. C.; Murphy, T. B.; Mimura-Kimura, Y.; Telford, J. E. Novel glycan biomarkers for the detection of lung cancer J. Proteome Res. 2011, 10 (4) 1755-1764
84. Vasseur, J. A.; Goetz, J. A.; Alley, W. R., Jr.; Novotny, M. V. Smoking and Lung Cancer-induced Changes in N-Glycosylation of Blood Serum Proteins Glycobiology 2012, 10.1093/glycob/cws108
85. Gornik, O.; Lauc, G. Glycosylation of serum proteins in inflammatory diseases Dis. Markers 2008, 25 (4-5) 267-278
86. McMillan, S. A.; Douglas, J. P.; Archbold, G. P.; McCrum, E. E.; Evans, A. E. Effect of low to moderate levels of smoking and alcohol consumption on serum immunoglobulin concentrations J. Clin. Pathol. 1997, 50 (10) 819-822
87. An, H. J.; Kronewitter, S. R.; de Leoz, M. L.; Lebrilla, C. B. Glycomics and disease markers Curr. Opin Chem. Biol. 2009, 13 (5-6) 601-607
88. Arnold, J. N.; Wormald, M. R.; Sim, R. B.; Rudd, P. M.; Dwek, R. A. The impact of glycosylation on the biological function and structure of human immunoglobulins Annu. Rev. Immunol. 2007, 25, 21-50
89. Gabay, C.; Kushner, I. Acute-phase proteins and other systemic responses to inflammation New Engl. J. Med. 1999, 340 (6) 448-454
90. Medzhitov, R. Origin and physiological roles of inflammation Nature 2008, 454 (7203) 428-435
91. Gornik, O.; Royle, L.; Harvey, D. J.; Radcliffe, C. M.; Saldova, R.; Dwek, R. A. Changes of serum glycans during sepsis and acute pancreatitis Glycobiology 2007, 17 (12) 1321-1332
92. Bone, R. C. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) Ann. Int. Med. 1996, 125 (8) 680-687
93. Stanta, J. L.; Saldova, R.; Struwe, W. B.; Byrne, J. C.; Leweke, F. M.; Rothermund, M. Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia J. Proteome Res. 2010, 9 (9) 4476-4489
94. Klein, A. Human total serum N-glycome Adv. Clin Chem. 2008, 46, 51-85
95. Callewaert, N.; Van Vlierberghe, H.; Van Hecke, A.; Laroy, W.; Delanghe, J.; Contreras, R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics Nature Med. 2004, 10 (4) 429-434
96. Liu, X. E.; Desmyter, L.; Gao, C. F.; Laroy, W.; Dewaele, S.; Vanhooren, V. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus Hepatology 2007, 46 (5) 1426-1435
97. Chen, C.; Schmilovitz-Weiss, H.; Liu, X. E.; Pappo, O.; Halpern, M.; Sulkes, J. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis J. Proteome Res. 2009, 8 (2) 463-470
98. Goodarzi, M. T.; Turner, G. A. Reproducible and sensitive determination of charged oligosaccharides from haptoglobin by PNGase F digestion and HPAEC/PAD analysis: glycan composition varies with disease Glycoconjugate J. 1998, 15 (5) 469-75
99. Sarrats, A.; Saldova, R.; Pla, E.; Fort, E.; Harvey, D. J.; Struwe, W. B. Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis Proteomics Clin. Appl. 2010, 4 (4) 432-448
100. Peracaula, R.; Sarrats, A.; Rudd, P. M. Liver proteins as sensor of human malignancies and inflammation Proteomics Clin. Appl. 2010, 4 (4) 426-431
101. Hashimoto, S.; Asao, T.; Takahashi, J.; Yagihashi, Y.; Nishimura, T.; Saniabadi, A. R. alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis Cancer 2004, 101 (12) 2825-2836
102. Qiu, Y.; Patwa, T. H.; Xu, L.; Shedden, K.; Misek, D. E.; Tuck, M. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot J. Proteome Res.. 2008, 7 (4) 1693-1703
103. Ueda, K.; Katagiri, T.; Shimada, T.; Irie, S.; Sato, T. A.; Nakamura, Y. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer J. Proteome Res. 2007, 6 (9) 3475-3483
104. Mega, T.; Lujan, E.; Yoshida, A. Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. II. Structure of oligosaccharides J. Biol. Chem. 1980, 255 (9) 4057-61
105. Hodges, L. C.; Laine, R.; Chan, S. K. Structure of the oligosaccharide chains in human alpha 1-protease inhibitor J. Biol. Chem. 1979, 254 (17) 8208-12
106. Packer, N. H.; MR, W. I.; Golaz, O.; Lawson, M. A.; Gooley, A. A.; Hochstrasser, D. F. Characterization of human plasma glycoproteins separated by two-dimensional gel electrophoresis Biotechnology (NY) 1996, 14 (1) 66-70
107. Mills, K.; Mills, P. B.; Clayton, P. T.; Johnson, A. W.; Whitehouse, D. B.; Winchester, B. G. Identification of alpha(1)-antitrypsin variants in plasma with the use of proteomic technology Clin. Chem. 2001, 47 (11) 2012-2022
108. Torossi, T.; Fan, J. Y.; Sauter-Etter, K.; Roth, J.; Ziak, M. Endomannosidase processes oligosaccharides of alpha1-antitrypsin and its naturally occurring genetic variants in the Golgi apparatus Cell. Mol. Life Sci. 2006, 63 (16) 1923-1932
109. Foreman, R. C. Alpha 1-antitrypsin deficiency - A defect in secretion Biosci. Rep. 1987, 7 (4) 307-311
110. Comunale, M. A.; Rodemich-Betesh, L.; Hafner, J.; Wang, M.; Norton, P.; Di Bisceglie, A. M. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: Implications for a biomarker of hepatocellular carcinoma PloS One 2010, 5 (8) e12419
111. Trombetta, E. S. The contribution of N-glycans and their processing in the endoplasmic reticulum to glycoprotein biosynthesis Glycobiology 2003, 13 (9) 77R-91R
112. Parodi, A. J. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation Biochemical J. 2000, 348 (Pt 1) 1-13
113. Hosokawa, N.; Tremblay, L. O.; You, Z.; Herscovics, A.; Wada, I.; Nagata, K. Enhancement of endoplasmic reticulum (ER) degradation of misfolded Null Hong Kong alpha1-antitrypsin by human ER mannosidase I J. Biol. Chem. 2003, 278 (28) 26287-94
114. Wu, Y.; Swulius, M. T.; Moremen, K. W.; Sifers, R. N. Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (14) 8229-34
115. Whisstock, J. C.; Skinner, R.; Carrell, R. W.; Lesk, A. M. Conformational changes in serpins: I. The native and cleaved conformations of alpha(1)-antitrypsin J. Mol. Biol. 2000, 296 (2) 685-699
116. Huntington, J. A.; Whisstock, J. C. Molecular contortionism-on the physical limits of serpin loop-sheet polymers Biological Chem. 2010, 391 (8) 973-982
117. Sarkar, A.; Wintrode, P. L. Effects of glycosylation on the stability and flexibility of a metastable protein: the human serpin alpha(1)-antitrypsin Int. J. Mass Spectrom. 2011, 302 (1-3) 69-75
118. Shental-Bechor, D.; Levy, Y. Folding of glycoproteins: toward understanding the biophysics of the glycosylation code Curr. Opin. Struct. Biol. 2009, 19 (5) 524-33
119. Varki, A. Biological roles of oligosaccharides: All of the theories are correct Glycobiology 1993, 3 (2) 97-130
120. Casolaro, M. A.; Fells, G.; Wewers, M.; Pierce, J. E.; Ogushi, F.; Hubbard, R. Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin J. Appl. Physiol 1987, 63 (5) 2015-23
121. Kwon, K. S.; Yu, M. H. Effect of glycosylation on the stability of alpha1-antitrypsin toward urea denaturation and thermal deactivation Biochim. Biophys. Acta 1997, 1335 (3) 265-72
122. Gross, V.; vom Berg, D.; Kreuzkamp, J.; Ganter, U.; Bauer, J.; Wurtemberger, G. Biosynthesis and secretion of M- and Z-type alpha 1-proteinase inhibitor by human monocytes. Effect of inhibitors of glycosylation and of oligosaccharide processing on secretion and function Biol. Chem. Hoppe-Seyler 1990, 371 (3) 231-238
123. McCarthy, C.; Saldova, R.; OBrien, M. E.; Bergin, D. A.; Carroll, T. P.; Keenan, J. Increased Outer Arm and Core Fucose Residues on the N-Glycans of Mutated Alpha-1 Antitrypsin Protein from Alpha-1 Antitrypsin Deficient Individuals J. Proteome Res. 2014, 13 (2) 596-605
124. ODwyer, C. A. M.; Reeves, N. G.; Alpha-1, E. P. antitrypsin inhibits leukotriene B4 neutrophil signalling through a mechanism that involves direct complexation of the two molecules Am. J. Respir. Crit. Care Med. 2013, 187, A2741
125. Bergin, D. A.; Reeves, E. P.; Hurley, K.; Wolfe, R.; Jameel, R.; Fitzgerald, S. The Circulating Proteinase Inhibitor alpha-1 Antitrypsin Regulates Neutrophil Degranulation and Autoimmunity Sci. Transl. Med. 2014, 6 (217) 217ra1
126. Griese, M.; Latzin, P.; Kappler, M.; Weckerle, K.; Heinzlmaier, T.; Bernhardt, T. Alpha 1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Eur. Respir. J. 2007, 29 (2) 240-250
127. Kalis, M.; Kumar, R.; Janciauskiene, S.; Salehi, A.; Cilio, C. M. Alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic beta-cells Islets 2010, 2 (3) 185-189
128. Al-Omari, M.; Korenbaum, E.; Ballmaier, M.; Lehmann, U.; Jonigk, D.; Manstein, D. J. Acute-phase protein alpha1-antitrypsin inhibits neutrophil calpain I and induces random migration Mol. Med. 2011, 17 (9-10) 865-874
129. Zhang, B.; Lu, Y.; Campbell-Thompson, M.; Spencer, T.; Wasserfall, C.; Atkinson, M. Alpha1-antitrypsin protects beta-cells from apoptosis Diabetes 2007, 56 (5) 1316-1323
130. Martin, S. L.; Downey, D.; Bilton, D.; Keogan, M. T.; Edgar, J.; Elborn, J. S. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis Pediatr. Pulmonol. 2006, 41 (2) 177-183
131. McElvaney, N. G.; Hubbard, R. C.; Birrer, P.; Chernick, M. S.; Caplan, D. B.; Frank, M. M. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis Lancet 1991, 337 (8738) 392-394
132. Hubbard, R. C.; McElvaney, N. G.; Sellers, S. E.; Healy, J. T.; Czerski, D. B. Crystal RG. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency J. Clin. Invest. 1989, 84 (4) 1349-1354
133. Perlmutter, D. H.; May, L. T.; Sehgal, P. B. Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells J. Clin. Invest. 1989, 84 (1) 138-144
134. Perlmutter, D. H.; Schlesinger, M. J.; Pierce, J. A.; Campbell, E. J.; Rothbaum, R. J.; Schwartz, A. L. Induction of the stress response in alpha 1-antitrypsin deficiency Trans. Assoc. Am. Physicians 1988, 101, 33-41
135. Perlmutter, D. H.; Travis, J.; Punsal, P. I. Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency J. Clin. Invest. 1988, 81 (6) 1774-1780
136. Knoell, D. L.; Ralston, D. R.; Coulter, K. R.; Wewers, M. D. Alpha 1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha in monocytes Am. J. Resp. Crit. Care Med. 1998, 157 (1) 246-255
137. Boutten, A.; Venembre, P.; Seta, N.; Hamelin, J.; Aubier, M.; Durand, G. Oncostatin M is a potent stimulator of alpha1-antitrypsin secretion in lung epithelial cells: modulation by transforming growth factor-beta and interferon-gamma Am. J. Respir. Cell Mol. Biol. 1998, 18 (4) 511-520
138. Mackiewicz, A.; Sobieska, M.; Kapcinska, M.; Mackiewicz, S. H.; Wiktorowicz, K. E.; Pawlowski, T. Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitro Ann. Rheum. Dis. 1992, 51 (1) 67-72
139. Pos, O.; van der Stelt, M. E.; Wolbink, G. J.; Nijsten, M. W.; van der Tempel, G. L.; van Dijk, W. Changes in the serum concentration and the glycosylation of human alpha 1-acid glycoprotein and alpha 1-protease inhibitor in severely burned persons: relation to interleukin-6 levels Clin. Exp. Immunol. 1990, 82 (3) 579-582
140. Mackiewicz, A.; Rose-John, S.; Schooltink, H.; Laciak, M.; Gorny, A.; Heinrich, P. C. Soluble human interleukin-6-receptor modulates interleukin-6-dependent N-glycosylation of alpha 1-protease inhibitor secreted by HepG2 cells FEBS Lett. 1992, 306 (2-3) 257-261
141. Saso, L.; Valentini, G.; Giardino, A. M.; Spadaro, A.; Riccieri, V.; Zoppini, A. Changes of glycosylation of serum proteins in psoriatic arthritis, studied by enzyme-linked lectin assay (ELLA), using concanavalin A Biochem. Mol. Biol. Int. 1998, 46 (5) 867-875
142. Mackiewicz, A.; Laciak, M.; Gorny, A.; Baumann, H. Leukemia inhibitory factor, interferon gamma and dexamethasone regulate N-glycosylation of alpha 1-protease inhibitor in human hepatoma cells Eur. J. Cell Biol. 1993, 60 (2) 331-336
143. Kulig, P.; Cichy, J. Acute phase mediator oncostatin M regulates affinity of alpha1-protease inhibitor for concanavalin A in hepatoma-derived but not lung-derived epithelial cells Cytokine 2005, 30 (5) 269-274
144. Kataoka, H.; Seguchi, K.; Inoue, T.; Koono, M. Properties of alpha 1-antitrypsin secreted by human adenocarcinoma cell lines FEBS Lett. 1993, 328 (3) 291-295
145. Arnold, J. N.; Saldova, R.; Hamid, U. M.; Rudd, P. M. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation Proteomics 2008, 8 (16) 3284-3293
146. Rostenberg, I.; Guizar-Vazquez, J.; Penaloza, R. Altered carbohydrate content of alpha1-antitrypsin in patients with cancer J. Natl. Cancer Inst. 1978, 61 (4) 961-965
147. Abd Hamid, U. M.; Royle, L.; Saldova, R.; Radcliffe, C. M.; Harvey, D. J.; Storr, S. J. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression Glycobiology 2008, 18 (12) 1105-1118
148. Sun, Z.; Yang, P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression Lancet Oncol. 2004, 5 (3) 182-190
149. Yang, P.; Bamlet, W. R.; Sun, Z.; Ebbert, J. O.; Aubry, M. C.; Krowka, M. J. Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk Chest 2005, 128 (1) 445-452
150. Schrodinger, L. The PyMOL Molecular Graphics System. Version 1.3r1 ed.; Schrodinger, LLC; 2010.
151. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H. The Protein Data Bank Nucleic Acids Res. 2000, 28 (1) 235-242
152. Patschull, A. O.; Segu, L.; Nyon, M. P.; Lomas, D. A.; Nobeli, I.; Barrett, T. E. Therapeutic target-site variability in alpha1-antitrypsin characterized at high resolution Acta Crystallogr. Sect. F 2011, 67 (Pt 12) 1492-7
153. Wormald, M. R.; Petrescu, A. J.; Pao, Y. L.; Glithero, A.; Elliott, T.; Dwek, R. A. Conformational studies of oligosaccharides and glycopeptides: complementarity of NMR, X-ray crystallography, and molecular modelling Chem. Rev. 2002, 102 (2) 371-86
154. Petrescu, A. J.; Milac, A. L.; Petrescu, S. M.; Dwek, R. A.; Wormald, M. R. Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding Glycobiology 2004, 14 (2) 103-14
155. 1-antitrypsin phenotyping with the Hydrasys System Clin Chem. Lab Med. 2008, 46 (2) 260-3
156. Fournier, T.; Medjoubi, N. N.; Porquet, D. Alpha-1-acid glycoprotein Biochim. Biophys. Acta 2000, 1482 (1-2) 157-71
157. Higai, K.; Aoki, Y.; Azuma, Y.; Matsumoto, K. Glycosylation of site-specific glycans of alpha1-acid glycoprotein and alterations in acute and chronic inflammation Biochim. Biophys. Acta 2005, 1725 (1) 128-35
158. Higai, K.; Azuma, Y.; Aoki, Y.; Matsumoto, K. Altered glycosylation of alpha1-acid glycoprotein in patients with inflammation and diabetes mellitus Clin. Chim. Acta 2003, 329 (1-2) 117-125
159. Brinkman-van der Linden, E. C.; de Haan, P. F.; Havenaar, E. C.; van Dijk, W. Inflammation-induced expression of sialyl LewisX is not restricted to alpha1-acid glycoprotein but also occurs to a lesser extent on alpha1-antichymotrypsin and haptoglobin Glycoconjugate J. 1998, 15 (2) 177-182
160. Al Murri, A. M.; Bartlett, J. M.; Canney, P. A.; Doughty, J. C.; Wilson, C.; McMillan, D. C. Evaluation of an inflammation-based prognostic score (GPS)
161. Saldova, R.; Royle, L.; Radcliffe, C. M.; Abd Hamid, U. M.; Evans, R.; Arnold, J. N. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG Glycobiology 2007, 17 (12) 1344-1356
162. Kossowska, B.; Ferens-Sieczkowska, M.; Gancarz, R.; Passowicz-Muszynska, E.; Jankowska, R. Fucosylation of serum glycoproteins in lung cancer patients Clin. Chem. Lab Med. 2005, 43 (4) 361-369
163. Fujimura, T.; Shinohara, Y.; Tissot, B.; Pang, P. C.; Kurogochi, M.; Saito, S. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects Int. J. Cancer 2008, 122 (1) 39-49
164. Hoagland, L., 4th; Campa, M. J.; Gottlin, E. B.; Herndon, J. E., 2nd; Patz, E. F., Jr. Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer Cancer 2007, 110 (10) 2260-8
165. Okuyama, N.; Ide, Y.; Nakano, M.; Nakagawa, T.; Yamanaka, K.; Moriwaki, K. Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation Int. J. Cancer 2006, 118 (11) 2803-2808
166. Nakano, M.; Nakagawa, T.; Ito, T.; Kitada, T.; Hijioka, T.; Kasahara, A. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers Int. J. Cancer 2008, 122 (10) 2301-2309
167. Thompson, S.; Dargan, E.; Turner, G. A. Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer Cancer Lett. 1992, 66 (1) 43-48
168. Thompson, S.; Turner, G. A. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera Br J. Cancer. 1987, 56 (5) 605-610
169. Turner, G. A. Haptoglobin. A potential reporter molecule for glycosylation changes in disease Adv. Exp. Med. Biol. 1995, 376, 231-238
170. Goodarzi, M. T.; Turner, G. A. Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer Clin. Chim. Acta 1995, 236 (2) 161-171
171. 1H-NMR spectroscopy and deglycosylation by N -glycanase Eur. J. Biochem./FEBS 1991, 197 (1) 209-215
172. Solis, D.; Feizi, T.; Yuen, C. T.; Lawson, A. M.; Harrison, R. A.; Loveless, R. W. Differential recognition by conglutinin and mannan-binding protein of N -glycans presented on neoglycolipids and glycoproteins with special reference to complement glycoprotein C3 and ribonuclease B J. Biol. Chem. 1994, 269 (15) 11555-62
173. Crispin, M. D.; Ritchie, G. E.; Critchley, A. J.; Morgan, B. P.; Wilson, I. A.; Dwek, R. A. Monoglucosylated glycans in the secreted human complement component C3: Implications for protein biosynthesis and structure FEBS Lett. 2004, 566 (1-3) 270-274
174. Halim, A.; Nilsson, J.; Ruetschi, U.; Hesse, C.; Larson, G. Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD Mol. Cell. Proteomics 2012, 11 (4) M111 013649